Andere Sprachen Recursion Pharmaceuticals, Inc.

Aktien

A3CM1C

US75629V1044

RXRX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:05 23.04.2024			% 5 Tage	% 1. Jan.
7.695 ^USD	+1.25%		+1.65%	-21.96%

18.04.	Insider von Recursion Pharmaceuticals verkaufte Aktien im Wert von 367.007 $, laut einer aktuellen SEC Einreichung	MT
16.04.	Recursion ernennt Najat Khan zum Chief R&D Officer und Chief Commercial Officer	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	18.04.
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	16.04.
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16.04.
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16.04.
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer	16.04.
Recursion to Participate in Upcoming Investor Conference	02.04.
Recursion to Participate in Upcoming Investor Conference	02.04.
Recursion Publishes Annual Environmental, Social and Governance Report	26.03.
50 valores para invertir en IA, salud, movilidad y energía	25.03.
50 aandelen om te beleggen in KI, gezondheid, mobiliteit en energie	23.03.
50 titoli per investire in AI, salute, mobilità ed energia	22.03.
50 valeurs pour investir dans l'IA, la Santé, la Mobilité et l'Energie	22.03.
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing	15.03.
Recursion Pharmaceuticals to Open London Office	11.03.
Recursion Announces Plans to Open New Office in London	11.03.
Recursion Announces Plans to Open New Office in London	11.03.
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01.03.
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01.03.
Recursion to Participate in Upcoming Investor Conferences	01.03.
Recursion to Participate in Upcoming Investor Conferences	01.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Recursion Pharmaceuticals, Inc.

Aktien

A3CM1C

US75629V1044

RXRX

Andere Sprachen

Filter